Radius Health Announces License and Development Agreement for Abaloparatide-SC with Teijin Limited in Japan
Teijin granted a right of reference to Radius regulatory data and use of Radius Intellectual Property for development, manufacture and commercialization of abaloparatide-SC for Japan, the largest market globally for bone anabolics. Radius to receive …